efavirenz · Powder

What changed in the last 90 days

Every detected change for efavirenz, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

• doravirine, islatravir· 1 maker
• emtricitabine, rilpivirine and tenofovir disoproxil fumarate· 1 maker
• emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide· 1 maker
• emtricitabine, rilpivirine, tenofovir disoproxil fumarate· 1 maker
• dolutegravir sodium and rilpivirine hydrochloride· 2 makers
• doravirine, lamivudine, and tenofovir disoproxil fumarate· 2 makers
• efavirenz, lamivudine and tenofovir disoproxil fumarate· 2 makers
• emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate· 2 makers
• doravirine· 5 makers
• efavirenz, emtricitabine and tenofovir disoproxil fumarate· 7 makers
• rilpivirine· 7 makers
• rilpivirine hydrochloride· 8 makers

Common questions

Is Efavirenz in shortage right now?

No. FDA does not currently list Efavirenz in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.

Who makes Efavirenz?

15 companies have marketed Efavirenz in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.

What does Efavirenz cost?

The typical pharmacy pays about $1.35 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.